The molecular diagnostics (MDx) market is estimated to be worth $16.6B in 2023, and expected to reach $28.6B by 2028, as “Rapid progress in technologies such as next-generation...

Dermatomycosis of the hair, skin, or nails is one of the most prevalent fungal infections worldwide, affecting 20–25% of the global population.1 The condition is caused by keratinolytic...

A large sample volume, open-assay, super-fast, ultra-sensitive, and sample-to-answer PCR instrument.

Women face diverse and unique health concerns that can affect their overall health and wellness. Additionally, women are more prone to certain infectious, autoimmune, and mental...

Human cytomegalovirus (CMV) could practically be a tale of two pathogens. Among healthy adults, CMV infections are quite common and largely asymptomatic. Indeed, by age 40, at...

Since becoming commercially available over the last 10–15 years, liquid biopsies have been enthusiastically embraced, particularly for noninvasive prenatal screening and increasingly...

Single test on BD MAX Molecular Diagnostic System identifies and differentiates multiple respiratory infectious diseases.

Despite global focus on the COVID-19 pandemic, the concern around antimicrobial resistance (AMR) has continued to grow, albeit a bit further in the background. In 2019, AMR was...

A new molecular diagnostic system to expand access to PCR testing in the U.S.

The 2022 Medical Laboratory Observer (MLO) State of the Industry (SOI) survey on molecular diagnostics revealed some intriguing insights on the use of molecular testing by U.S...